These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 33251216)

  • 1. Molecular Crosstalk Between MYC and HIF in Cancer.
    Li Y; Sun XX; Qian DZ; Dai MS
    Front Cell Dev Biol; 2020; 8():590576. PubMed ID: 33251216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of the hypoxia-inducible factor 2α nuclear interactome in melanoma cells reveals master proteins involved in melanoma development.
    Steunou AL; Ducoux-Petit M; Lazar I; Monsarrat B; Erard M; Muller C; Clottes E; Burlet-Schiltz O; Nieto L
    Mol Cell Proteomics; 2013 Mar; 12(3):736-48. PubMed ID: 23275444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. c-Myc is regulated by HIF-2α in chronic hypoxia and influences sensitivity to 5-FU in colon cancer.
    Wang L; Xue M; Chung DC
    Oncotarget; 2016 Nov; 7(48):78910-78917. PubMed ID: 27793037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction and Collaboration of SP1, HIF-1, and MYC in Regulating the Expression of Cancer-Related Genes to Further Enhance Anticancer Drug Development.
    Kimura K; Jackson TLB; Huang RCC
    Curr Issues Mol Biol; 2023 Nov; 45(11):9262-9283. PubMed ID: 37998757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The hypoxia-inducible factors HIF1α and HIF2α are dispensable for embryonic muscle development but essential for postnatal muscle regeneration.
    Yang X; Yang S; Wang C; Kuang S
    J Biol Chem; 2017 Apr; 292(14):5981-5991. PubMed ID: 28232488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opposing effects of HIF1α and HIF2α on chromaffin cell phenotypic features and tumor cell proliferation: Insights from MYC-associated factor X.
    Qin N; de Cubas AA; Garcia-Martin R; Richter S; Peitzsch M; Menschikowski M; Lenders JW; Timmers HJ; Mannelli M; Opocher G; Economopoulou M; Siegert G; Chavakis T; Pacak K; Robledo M; Eisenhofer G
    Int J Cancer; 2014 Nov; 135(9):2054-64. PubMed ID: 24676840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential role of the N-MYC downstream-regulated gene family in reprogramming cancer metabolism under hypoxia.
    Lee GY; Chun YS; Shin HW; Park JW
    Oncotarget; 2016 Aug; 7(35):57442-57451. PubMed ID: 27447861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myc posttranscriptionally induces HIF1 protein and target gene expression in normal and cancer cells.
    Doe MR; Ascano JM; Kaur M; Cole MD
    Cancer Res; 2012 Feb; 72(4):949-57. PubMed ID: 22186139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIF-1alpha induces cell cycle arrest by functionally counteracting Myc.
    Koshiji M; Kageyama Y; Pete EA; Horikawa I; Barrett JC; Huang LE
    EMBO J; 2004 May; 23(9):1949-56. PubMed ID: 15071503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Latent Kaposi's sarcoma-associated herpesvirus infection of endothelial cells activates hypoxia-induced factors.
    Carroll PA; Kenerson HL; Yeung RS; Lagunoff M
    J Virol; 2006 Nov; 80(21):10802-12. PubMed ID: 16956952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The interplay between MYC and HIF in the Warburg effect.
    Dang CV
    Ernst Schering Found Symp Proc; 2007; (4):35-53. PubMed ID: 18811052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of hypoxia on the pathogenesis and therapy resistance in multiple myeloma.
    Ikeda S; Tagawa H
    Cancer Sci; 2021 Oct; 112(10):3995-4004. PubMed ID: 34310776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The interplay between MYC and HIF in cancer.
    Dang CV; Kim JW; Gao P; Yustein J
    Nat Rev Cancer; 2008 Jan; 8(1):51-6. PubMed ID: 18046334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of the hypoxia-inducible factor in tumor metabolism growth and invasion.
    Brahimi-Horn C; Pouysségur J
    Bull Cancer; 2006 Aug; 93(8):E73-80. PubMed ID: 16935775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A therapeutic role for targeting c-Myc/Hif-1-dependent signaling pathways.
    Podar K; Anderson KC
    Cell Cycle; 2010 May; 9(9):1722-8. PubMed ID: 20404562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ways into Understanding HIF Inhibition.
    Schönberger T; Fandrey J; Prost-Fingerle K
    Cancers (Basel); 2021 Jan; 13(1):. PubMed ID: 33466454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitor of differentiation 1 transcription factor promotes metabolic reprogramming in hepatocellular carcinoma cells.
    Sharma BK; Kolhe R; Black SM; Keller JR; Mivechi NF; Satyanarayana A
    FASEB J; 2016 Jan; 30(1):262-75. PubMed ID: 26330493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. c-Myc sensitization to oxygen deprivation-induced cell death is dependent on Bax/Bak, but is independent of p53 and hypoxia-inducible factor-1.
    Brunelle JK; Santore MT; Budinger GR; Tang Y; Barrett TA; Zong WX; Kandel E; Keith B; Simon MC; Thompson CB; Hay N; Chandel NS
    J Biol Chem; 2004 Feb; 279(6):4305-12. PubMed ID: 14627695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoxia-induced suppression of c-Myc by HIF-2α in human pulmonary endothelial cells attenuates TFAM expression.
    Zarrabi AJ; Kao D; Nguyen DT; Loscalzo J; Handy DE
    Cell Signal; 2017 Oct; 38():230-237. PubMed ID: 28709643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carrot and stick: HIF-alpha engages c-Myc in hypoxic adaptation.
    Huang LE
    Cell Death Differ; 2008 Apr; 15(4):672-7. PubMed ID: 18188166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.